Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo.
Krishnamurti
C
C
Division of Medicine, Walter Reed Army Institute of Research, Washington, D.C. 20307-5100.
Alving
B M
BM
D000818:Animals; D003327:Coronary Disease / Q000097:blood; D005260:Female; D005342:Fibrinolysis; D006023:Glycoproteins / Q000494:pharmacology; D006801:Humans; D007239:Infections / Q000097:blood; D015849:Plasminogen Inactivators / Q000378:metabolism*; D011247:Pregnancy / Q000097:blood; D011486:Protein C / Q000494:pharmacology; D012189:Retrospective Studies; D015843:Serpins / Q000235:genetics; D013927:Thrombosis / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000037:antagonists & inhibitors*; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors*; D019096:Vitronectin
D006023:Glycoproteins; D015849:Plasminogen Inactivators; D011486:Protein C; D015843:Serpins; D019096:Vitronectin; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator